InvestorsHub Logo
Followers 119
Posts 77595
Boards Moderated 4
Alias Born 05/26/2004

Re: None

Sunday, 03/01/2015 7:25:11 PM

Sunday, March 01, 2015 7:25:11 PM

Post# of 704570
Huge! $AMGN - Kyprolis beats Velcade in ENDEAVOR relapsed multiple myeloma study. median PFS 18.7 mos. vs. 9.4 mos. HR=0.53

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.